Driving CARs to BARs: The Winding Road to Specific Regulatory T Cells for Tolerance
Chimeric antigen receptor (CAR) transduced T cells have significantly improved cancer immunotherapy. Similarly, engineering regulatory T cells (Treg) with specific receptors to endow specificity and increase efficacy of Tregs holds great promise for therapy of a variety of adverse immune responses....
Main Author: | David W. Scott |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.742719/full |
Similar Items
-
Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
by: Qunfang Zhang, et al.
Published: (2018-10-01) -
Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision
by: Patrick R. Adair, et al.
Published: (2017-09-01) -
In Vivo Induction of Regulatory T Cells Via CTLA‐4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse
by: Gil‐Ran Kim, et al.
Published: (2021-07-01) -
Tuning the performance of CAR T cell immunotherapies
by: Noah H. Richardson, et al.
Published: (2019-11-01) -
Epitope-Specific Tolerance Modes Differentially Specify Susceptibility to Proteolipid Protein-Induced Experimental Autoimmune Encephalomyelitis
by: Lei Wang, et al.
Published: (2017-11-01)